A Temporal Narrative View of Sensemaking
Organization Theory · 2022-10 · 3 (4)
DOI: 10.1177/26317877221131585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organization Theory, online erschienen am 09.12.2022. Verfasst von Tor Hernes und 1 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Velux Fonden, Novo Nordisk Fonden.
Abstract (Originalsprache)
This paper contributes a narrative dimension for the temporality of organizational sensemaking. Reconciling sensemaking with a broader understanding of time not only provides a more in-depth treatment of time in sensemaking. It also helps overcome existing dichotomies in temporal theorizing to advance a more dynamic temporal theorizing in organizational research. To extend a temporal understanding of sensemaking, we discuss Ricoeur’s theory of narrative and time in light of his prefigurative, configurative, and refigurative modes of time. We then suggest ways that this framework illuminates how three corresponding temporal modes of sensemaking connect through time, drawing on Weick’s analysis of the Mann Gulch disaster to illustrate the framework. Finally, we discuss how the recursive features of our framework enable understanding of the situated dynamics by which actors move through time, thus contributing a way to deal with the “stationarity problem” of temporal theorizing.
Förderung
- Velux Fonden
- Novo Nordisk Fonden
Zitieren
APA
Hernes, T., & Obstfeld, D. (2022). A Temporal Narrative View of Sensemaking. Organization Theory, 3(4). https://doi.org/10.1177/26317877221131585
Vancouver
Hernes T, Obstfeld D. A Temporal Narrative View of Sensemaking. Organization Theory. 2022;3(4). doi:10.1177/26317877221131585
BibTeX
@article{Hernes2022,
author = {Hernes, Tor and Obstfeld, David},
title = {A Temporal Narrative View of Sensemaking},
journal = {Organization Theory},
year = {2022},
volume = {3},
number = {4},
doi = {10.1177/26317877221131585}
}
EUVIMED